Transfusion Medicine: The Invisible Consult Service
- 2 hours ago
- 3 min read
There is a particular kind of email that transfusion medicine physicians learn to recognize. It arrives a day or two after an event — a transfusion reaction, a complicated crossmatch, a patient with antibodies nobody quite knew what to do with. The subject line is something like quick question or following up, and the body begins: I wasn't sure if I was supposed to call you.
You weren't sure if you were supposed to call us.
This is not a failure of clinical judgment. It is a failure of visibility — and it is one of the most common problems in transfusion medicine, at almost every institution I have ever encountered.
Transfusion medicine occupies a strange position in the hospital ecosystem. We are essential infrastructure — the blood bank is running constantly, processing samples, issuing products, catching incompatibilities before they reach patients — but we are largely invisible to the clinicians ordering the blood. We are the electrical grid. You don't think about us until the lights go out.
The problem has two distinct roots, and they compound each other.
The first is awareness. Many clinicians — including experienced hospitalists, surgeons, and intensivists — do not know that a transfusion medicine consultation service exists, or that there is a physician available to answer questions around the clock. They know there is a blood bank. They may not know there is a board certified physician attached to the blood bank.
The second is uncertainty about when to call. Even clinicians who know we exist often hesitate, unsure whether their situation is "bad enough" to warrant a consult. A patient ran a fever during a transfusion — is that ours? The blood bank flagged an antibody — does someone need to talk to me? There is no obvious threshold, no shared mental model of what transfusion medicine is for beyond the most catastrophic scenarios.
The result is a gap. Reactions get managed in isolation. Antibody workups proceed without clinical context. Patients occasionally get the right outcome anyway — and occasionally don't.
The febrile non-hemolytic transfusion reaction is a useful illustration of both problems at once.
FNHTR is common, manageable, and almost never dangerous. Stop the transfusion, give acetaminophen, observe, document. Most hospitalists handle this appropriately without ever calling anyone. That's correct — FNHTR does not require a transfusion medicine consult.
But here is where it gets complicated: FNHTR is a diagnosis of exclusion. You can only call it benign after you've ruled out the things that aren't — acute hemolytic reaction, septic transfusion reaction, early TRALI. The fever threshold matters. The hemodynamic picture matters. The timing matters. And a hospitalist who has never been walked through that differential is making a judgment call without a map.
Most of the time, the call is right. But "most of the time" is a fragile foundation for patient safety, and the gap between managed correctly in isolation and should have called us is narrower than it looks in the moment.
I made a resource. It's linked below — a one-page clinical reference for exactly this decision: when to call transfusion medicine, when to monitor, and what to look for in the five reactions that cannot be missed.
It is not a substitute for a consult when you are unsure. That's the other thing I want to say plainly: uncertainty is a valid reason to call. You do not need to have a confirmed hemolytic reaction in front of you to page transfusion medicine. You just need to be unsure. That's enough.
We exist. We are available. We want to hear from you before things go wrong — and that is not a high bar. It is just a call.
